πŸ‡ΊπŸ‡Έ FDA
Patent

US 11858915

Polo like kinase 4 inhibitors

granted A61KA61K31/416A61K31/4439

Quick answer

US patent 11858915 (Polo like kinase 4 inhibitors) held by ORIC PHARMACEUTICALS, INC. expires Mon Dec 28 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
ORIC PHARMACEUTICALS, INC.
Grant date
Tue Jan 02 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 28 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61K, A61K31/416, A61K31/4439, A61K31/497, A61K31/513